The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer

被引:11
|
作者
Brenne, Elisabeth [1 ,2 ]
Loge, Jon H. [1 ,3 ]
Lie, Hanne [3 ]
Hjermstad, Marianne J. [1 ,4 ]
Fayers, Peter M. [1 ,5 ]
Kaasa, Stein [1 ,2 ]
机构
[1] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, European Palliat Care Res Ctr, N-7491 Trondheim, Norway
[2] Univ Trondheim Hosp, St Olavs Hosp, Canc Clin, Trondheim, Norway
[3] Univ Oslo, Inst Basic Med Sci, Dept Behav Sci Med, Oslo, Norway
[4] Oslo Univ Hosp, South Eastern Norway, Reg Ctr Excellence Palliat Care, Oslo, Norway
[5] Univ Aberdeen, Sch Med, Dept Publ Hlth, Aberdeen AB9 2ZD, Scotland
关键词
Palliative care; neoplasms; depression; depressive disorder; symptom assessment; REPORTED OUTCOME MEASURES; PALLIATIVE CARE RESEARCH; HEALTH QUESTIONNAIRE; DIAGNOSTIC-ACCURACY; TOOL; VALIDITY; DISTRESS; ANXIETY; PREVALENCE; VALIDATION;
D O I
10.1177/0269216315620082
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Depressive symptoms are prevalent in patients with advanced cancer, sometimes of a severity that fulfil the criteria for a major depressive episode. Aim: The aim of this study was to investigate how the item on depression in the Edmonton Symptom Assessment System with a 0-10 Numerical Rating Scale performed as a screener for major depressive episode. A possible improved performance by adding the Edmonton Symptom Assessment System-Anxiety item was also examined. Design: An international cross-sectional study including patients with incurable cancer was conducted. The Edmonton Symptom Assessment System score was compared against major depressive episode as assessed by the Patient Health Questionnaire-9. Screening performance was examined by sensitivity, specificity and the kappa coefficient. Setting: Patients with incurable cancer (n=969), median age 63years and from eight nationalities provided report. Median Karnofsky Performance Status was 70. Median survival was 229days (205-255days). Results: Patient Health Questionnaire-9 major depressive episode was present in 133 of 969 patients (13.7%). Edmonton Symptom Assessment System-Depression screening ability for Patient Health Questionnaire-9 major depressive episode was limited. Area under the receiver operating characteristic curve was 0.71 (0.66-0.76). Valid detection or exclusion of Patient Health Questionnaire-9 major depressive episode could not be concluded at any Edmonton Symptom Assessment System-Depression cut-off; by the cut-off Numerical Rating Scale2, sensitivity was 0.69 and specificity was 0.60. By the cut-off Numerical Rating Scale4, sensitivity was 0.51 and specificity was 0.82. Combined mean ratings by Edmonton Symptom Assessment System-Depression and Edmonton Symptom Assessment System-Anxiety revealed similar limited screening ability. Conclusion: The depression and anxiety items of the Edmonton Symptom Assessment System, a frequently used assessment tool in palliative care settings, seem to measure a construct other than major depressive episode as assessed by the Patient Health Questionnaire-9 instrument.
引用
收藏
页码:587 / 598
页数:12
相关论文
共 50 条
  • [1] Screening for symptoms of anxiety and depression in patients treated with renal replacement therapy: utility of the Edmonton Symptom Assessment System-Revised
    Tang, Evan
    Dano, Sumaya
    Edwards, Nathaniel
    Macanovic, Sara
    Ford, Heather
    Bartlett, Susan
    Howell, Doris
    Li, Madeline
    Novak, Marta
    Mucsi, Istvan
    QUALITY OF LIFE RESEARCH, 2022, 31 (02) : 597 - 605
  • [2] Validation of the Edmonton Symptom Assessment System in Korean Patients With Cancer
    Kwon, Jung Hye
    Nam, Seung-Hyun
    Koh, Sujin
    Hong, Young Seon
    Lee, Kyung Hee
    Shin, Sang-Won
    Hui, David
    Park, Kyun Woo
    Yoon, So Young
    Won, Ji Yun
    Chisholm, Gary
    Bruera, Eduardo
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 46 (06) : 947 - 956
  • [3] The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement
    Watanabe, Sharon M.
    Nekolaichuk, Cheryl L.
    Beaumont, Crystal
    PSYCHO-ONCOLOGY, 2012, 21 (09) : 977 - 985
  • [4] The Accuracy of the Edmonton Symptom Assessment System for the Assessment of Depression in Patients With Cancer: A Systematic Review and Meta-Analysis
    Boonyathee, Sorawit
    Nagaviroj, Kittiphon
    Anothaisintawee, Thunyarat
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2018, 35 (04): : 731 - 739
  • [5] Validation of the Dutch version of the Edmonton Symptom Assessment System
    van der Baan, Frederieke H.
    Koldenhof, Josephine J.
    de Nijs, Ellen J.
    Echteld, Michael A.
    Zweers, Danielle
    Hesselmann, Ginette M.
    Vervoort, Sigrid C.
    Vos, Jan B.
    de Graaf, Everlien
    Witteveen, Petronella O.
    Suijkerbuijk, Karijn P.
    de Graeff, Alexander
    Teunissen, Saskia C.
    CANCER MEDICINE, 2020, 9 (17): : 6111 - 6121
  • [6] Implementation of the Edmonton Symptom Assessment System for Symptom Distress Screening at a Community Cancer Center: A Pilot Program
    Hui, David
    Titus, Annie
    Curtis, Tiffany
    Ho-Nguyen, Vivian Trang
    Frederickson, Delisa
    Wray, Curtis
    Granville, Tenisha
    Bruera, Eduardo
    McKee, Donna K.
    Rieber, Alyssa
    ONCOLOGIST, 2017, 22 (08): : 995 - 1001
  • [7] A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients
    Carvajal, Ana
    Centeno, Carlos
    Watson, Roger
    Bruera, Eduardo
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (12) : 1863 - 1872
  • [8] Symptom correlates of dyspnea in advanced cancer patients using the Edmonton Symptom Assessment System
    McKenzie, Erin
    Zhang, Liying
    Chan, Stephanie
    Zaki, Pearl
    Razvi, Yasmeen
    Tsao, May
    Barnes, Elizabeth
    Drost, Leah
    Yee, Caitlin
    Hwang, Matthew
    DeAngelis, Carlo
    Chow, Edward
    SUPPORTIVE CARE IN CANCER, 2020, 28 (01) : 87 - 98
  • [9] The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression
    Bagha, S. M.
    Macedo, A.
    Jacks, L. M.
    Lo, C.
    Zimmermann, C.
    Rodin, G.
    Li, M.
    EUROPEAN JOURNAL OF CANCER CARE, 2013, 22 (01) : 60 - 69
  • [10] Screening Performance of Edmonton Symptom Assessment System in Kidney Transplant Recipients
    Battaglia, Yuri
    Zerbinati, Luigi
    Piazza, Giulia
    Martino, Elena
    Provenzano, Michele
    Esposito, Pasquale
    Massarenti, Sara
    Andreucci, Michele
    Storari, Alda
    Grassi, Luigi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)